GlassScriptPhysician profile
Dana Lynn Shields
NPI 1083073803
$597.65
in general payments reported to CMS, 2019-2025
16 companies · $102 in 2025
The $102 reported for 2025 was more than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $133 · 2022: $125 · 2023: $140 · 2024: $97.75 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $100.57 | 2021-2022 | |
| Shield Therapeutics INC | $88.05 | 2022-2024 | Accrufer |
| Sumitomo Pharma America, INC. | $69.87 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $62.43 | 2022-2023 | |
| Exact Sciences Corporation | $44.50 | 2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $32.83 | 2024 | Veozah |
| Abbvie INC. | $31.36 | 2023 | |
| Sage Therapeutics, LLC | $30.68 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $29.35 | 2025 | |
| Evofem Biosciences, INC. | $28.49 | 2021 | |
| Myovant Sciences INC. | $18.37 | 2021 | |
| Pfizer INC. | $16.99 | 2024 | |
| Amag Pharmaceuticals, INC. | $15.18 | 2021 | |
| Lupin INC. | $14.38 | 2021 | |
| Novo Nordisk INC | $11.83 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $2.77 | 2025 | Jada System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Shields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.